Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Respirology (Carlton, Vic.)|March 26, 2019
Metabolomics in chronic lung diseasesShabarinath Nambiar, Sze Bong How, Joel Gummer, et al.
American Journal of Physiology. Cell Physiology|September 25, 2023
The role of the host-microbiome and metabolomics in sarcoidosisJunwoo Kim, Silvia Lee, Yuben Moodley, et al.
Stem Cell Research & Therapy|June 5, 2020
Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosisBelén Alvarez-Palomo, Luis Ignacio Sanchez-Lopez, Yuben Moodley, et al.
Stem Cell Research & Therapy|June 14, 2018
Epithelial disruption: a new paradigm enabling human airway stem cell transplantationNigel Farrow, Patricia Cmielewski, Martin Donnelley, et al.
Therapeutic Advances in Respiratory Disease|May 3, 2025
Treatable traits in interstitial lung disease: a narrative reviewMegan Harrison, Chloe Lawler, Fiona Lake, et al.
Stem Cell Research|May 28, 2016
Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injuryYuben Moodley, Marian Sturm, Kathryn Shaw, et al.
The American Journal of Pathology|June 6, 2009
Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injuryYuben Moodley, Daniel Atienza, Ursula Manuelpillai, et al.
BMC Pulmonary Medicine|February 3, 2016
Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centresHelen E Jo, Tamera J Corte, Yuben Moodley, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2010
Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repairYuben Moodley, Sivagami Ilancheran, Chrishan Samuel, et al.
Plos One|August 13, 2013
Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative studyYuben Moodley, Vijesh Vaghjiani, James Chan, et al.
Pageof 6